Phosphoantigen recognition by Vγ9Vδ2 T cells

Area of Science:

• Immunology
• Cellular Biology
• Biochemistry

Background:

• Vγ9Vδ2 T cells are key immune cells with antimicrobial and antitumor potential.
• Their activation relies on the Vγ9Vδ2 T-cell receptor (TCR) interacting with phosphoantigens (PAg).
• PAg are intermediates of isoprenoid synthesis, elevated in certain cancers and after aminobisphosphonate treatment.

Purpose of the Study:

• To review progress in understanding phosphoantigen (PAg) recognition by Vγ9Vδ2 T cells.
• To investigate the interaction between butyrophilins (BTN) and PAg.
• To propose a model for Vγ9Vδ2 T-cell receptor activation complex formation.

Main Methods:

• Literature review focusing on PAg recognition and BTN interactions.
• Phylogenetic analysis of butyrophilins and Vγ9Vδ2 T cells, including human and alpaca comparisons.
• Development of a composite ligand model for Vγ9Vδ2 TCR activation.

Main Results:

• A composite ligand model is proposed, involving BTN3A1-A2/A3 heteromers and BTN2A1 homodimers forming the Vγ9Vδ2 TCR activating complex.
• PAg binding to the intracellular BTN3A1-B30.2 domain initiates complex formation with BTN2A1 B30.2 domains.
• Extracellular interactions involve BTN2A1-IgV binding to Vγ9-TCR framework and BTN3A-IgV to TCR complementarity determining regions.

Conclusions:

• The proposed model provides a framework for understanding PAg-recognition and Vγ9Vδ2 T-cell activation.
• Further research is needed to address unresolved questions regarding the structural basis and physiological consequences of PAg recognition.
• This work highlights the importance of BTN-PAg interactions in Vγ9Vδ2 T cell immunity and immunotherapy.